Bucindolol: Effects on blood pressure, airways resistance and serum creatine phosphokinase
- 1 January 1984
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 27 (3) , 265-268
- https://doi.org/10.1007/bf00542157
Abstract
Summary The effect of bucindolol on pulse, blood pressure and airways resistance was studied in eight patients. One hour after 150 mg bucindolol, a significant decrease in supine, standing and post-exercise blood pressure was observed. No change in blood pressure occurred 10 to 14 h after doses ranging from 50–150 mg indicating that bucindolol has a relatively short duration of action. A dose related inhibition of excercise induced tachycardia was observed consistant with beta-receptor blocking activity. However, there was no change in the resting pulse indicating partial sympathomimetic activity. There was no increase in airways resistance at all doses of bucindolol. Serum creatine phosphokinase increased beyond normal limits in 3 out of 6 patients studied, probably due to a direct effect upon skeletal muscle.Keywords
This publication has 14 references indexed in Scilit:
- Assessment of beta-adrenoceptor antagonists in asthmatic patients.Published by Wiley ,1982
- Labetalol-induced toxic myopathy.BMJ, 1981
- Elevation of serum creatine phosphokinase during pindolol treatment.The Tohoku Journal of Experimental Medicine, 1981
- β-adrenoceptor and cardiovascular effects of MJ 13105 (Bucindolol) in anesthetized dogs and ratsEuropean Journal of Pharmacology, 1980
- Proximal myopathy during beta-blockade.BMJ, 1979
- Beta-blockers and asthma.Heart, 1978
- MYOTONIA PRECIPITATED BY PROPRANOLOL THERAPYThe Lancet, 1977
- The effect of thymoxamine and cromolyn sodium on postexercise bronchoconstriction in asthmaJournal of Allergy and Clinical Immunology, 1976
- New Approach to Assessment of Cardioselectivity of Beta-blocking DrugsBMJ, 1974
- EFFECT OF A β-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICSThe Lancet, 1964